Laura Bornes

Mrs. Laura Bornes

Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2020 in Cell Stem Cell
Verified
Journal Article
Open access
PDF file
AFArianna Fumagalli
Arianna Fumagalli
KOKoen C. Oost
Koen C. Oost
LKLennart Kester
Lennart Kester
JMJessica Morgner
Jessica Morgner
LBLaura Bornes
Laura Bornes
JRJacco Van Rheenen
Jacco Van Rheenen
Colorectal cancer stem cells (CSCs) express Lgr5 and display extensive stem cell-like multipotency and self-renewal and are thought to seed metastatic disease. Here, we used a mouse model of colorectal cancer (CRC) and human tumor xenografts to investigate the cell of origin of metastases. We found that most disseminated CRC cells in circulation were Lgr5− and formed distant metastases in which Lgr5+ CSCs appeared. This plasticity occurred independently of stemness-inducing microenvironmental factors and was indispensable for outgrowth, but not establishment, of metastases. Together, these findings show that most colorectal cancer metastases are seeded by Lgr5− cells, which display intrinsic capacity to become CSCs in a niche-independent manner and can restore epithelial hierarchies in metastatic tumors.

18 May 2022 in Nature
Verified
Journal Article
Closed access
PDF file
MRMatteo Rossi
Matteo Rossi
PAPatricia Altea-Manzano
Patricia Altea-Manzano
MDMargherita Demicco
Margherita Demicco
GDGinevra Doglioni
Ginevra Doglioni
LBLaura Bornes
Laura Bornes
SFSarah-Maria Fendt
Sarah-Maria Fendt

9 March 2020 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
MHMirjam E. Hoekstra
Mirjam E. Hoekstra
LBLaura Bornes
Laura Bornes
FDFeline E. Dijkgraaf
Feline E. Dijkgraaf
DPDaisy Philips
Daisy Philips
IPIris N. Pardieck
Iris N. Pardieck
TSTon N. M. Schumacher
Ton N. M. Schumacher

Verified
Journal Article
Open access
PDF file
LBLaura Bornes
Laura Bornes
GBGuillaume Belthier
Guillaume Belthier
JRJacco Van Rheenen
Jacco Van Rheenen
Epithelial-to-mesenchymal transition (EMT) is a cellular program which leads to cells losing epithelial features, including cell polarity, cell–cell adhesion and attachment to the basement membrane, while gaining mesenchymal characteristics, such as invasive properties and stemness. This program is involved in embryogenesis, wound healing and cancer progression. Over the years, the role of EMT in cancer progression has been heavily debated, and the requirement of this process in metastasis even has been disputed. In this review, we discuss previous discrepancies in the light of recent findings on EMT, plasticity and hybrid E/M states. Moreover, we highlight various tumor microenvironmental cues and cell intrinsic signaling pathways that induce and sustain EMT programs, plasticity and hybrid E/M states. Lastly, we discuss how recent findings on plasticity, especially on those that enable cells to switch between hybrid E/M states, have changed our understanding on the role of EMT in cancer metastasis, stemness and therapy resistance.

4 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
MCMarta Ciwinska
Marta Ciwinska
HMHendrik A. Messal
Hendrik A. Messal
HHHristina R. Hristova
Hristina R. Hristova
CLCatrin Lutz
Catrin Lutz
LBLaura Bornes
Laura Bornes
CSColinda L. G. J. Scheele
Colinda L. G. J. Scheele
Oncogenic mutations are abundant in the tissues of healthy individuals, but rarely form tumours1–3. Yet, the underlying protection mechanisms are largely unknown. To resolve these mechanisms in mouse mammary tissue, we use lineage tracing to map the fate of wild-type and Brca1−/−;Trp53−/− cells, and find that both follow a similar pattern of loss and spread within ducts. Clonal analysis reveals that ducts consist of small repetitive units of self-renewing cells that give rise to short-lived descendants. This offers a first layer of protection as any descendants, including oncogenic mutant cells, are constantly lost, thereby limiting the spread of mutations to a single stem cell-descendant unit. Local tissue remodelling during consecutive oestrous cycles leads to the cooperative and stochastic loss and replacement of self-renewing cells. This process provides a second layer of protection, leading to the elimination of most mutant clones while enabling the minority that by chance survive to expand beyond the stem cell-descendant unit. This leads to fields of mutant cells spanning large parts of the epithelial network, predisposing it for transformation. Eventually, clone expansion becomes restrained by the geometry of the ducts, providing a third layer of protection. Together, these mechanisms act to eliminate most cells that acquire somatic mutations at the expense of driving the accelerated expansion of a minority of cells, which can colonize large areas, leading to field cancerization.

1 November 2019 in Cell Reports
Verified
Journal Article
Open access
LBLaura Bornes
Laura Bornes
RSRoan Hugo van Scheppingen
Roan Hugo van Scheppingen
EBEvelyne Beerling
Evelyne Beerling
TSTim Schelfhorst
Tim Schelfhorst
SESaskia Inge Johanna Ellenbroek
Saskia Inge Johanna Ellenbroek
JRJacco Van Rheenen
Jacco Van Rheenen
Epithelial-to-mesenchymal transition (EMT) has long been thought to be crucial for metastasis. Recently a study challenged this idea by demonstrating that metastases were seeded by tumor cells that were not marked by an EMT lineage-tracing reporter on the basis of the expression of the mesenchymal marker fsp1. However, the results of this study and their interpretation are under debate. Here, we combine the lineage-tracing reporter with our real-time EMT-state reporter and show that the fsp1-based EMT lineage-tracing reporter does not mark all disseminating mesenchymal cells with metastatic potential. Our findings demonstrate that fsp1-mediated lineage tracing does not allow any conclusions about the requirement of EMT for metastasis. Instead our data are fully consistent with previous reports that EMT is not a binary phenomenon but rather a spectrum of cellular states.